Safety and efficacy of dimethyl fumarate in patients with primary progressive multiple sclerosis: A double-blind, randomized phase 2 trial

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2020
This article has no abstract
Epistemonikos ID: 8315d0dfac7f00fb2b786131eccd172e6e422ac8
First added on: Apr 30, 2026